Clinical Trials Logo
  1. Home
  2. Endometriosis
  3. NCT05312528
  4. Details
NCT05312528 Clinical Trial

Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

Endometriosis Clinical Trial

Official title:
Diagnostic Value of Annexin V, sVCAM-1, sICAM-1, Vascular Endothelial Growth Factor, TNF Alpha and Interleukin-6 in Ovarian and Deep Infiltrating Endometriosis, the Changes of These Markers in the Postoperative Period

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05312528
Other study ID # 2018.01.1.01.001
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2018
Est. completion date March 1, 2019

Study information
Verified date March 2022
Source Bagcilar Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The diagnostic value of Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and Proinflammatory cytokines (TNF-a and interleukin-6) in ovarian endometriosis and deep infiltrating endometriosis, their levels in organ-specific involvement, their relationship with symptoms, and the changes of these markers in the postoperative period will be evaluated.

Description:

Serum Annexin V, sVCAM-1, sICAM-1, vascular endothelial growth factor and proinflammatory cytokines (TNF-a and interleukin-6) values were studied by taking blood samples from all patients before and three months after the operation.

Recruitment information / eligibility
Status Completed
Enrollment 79
Est. completion date March 1, 2019
Est. primary completion date February 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: 1. Stage III and IV endometriosis patients requiring surgery due to chronic pelvic pain or suspected malignancy Exclusion Criteria: 1. Malignant disease 2. Ovarian failure 3. Acute pelvic inflammatory disease 4. Smokers 5. Pregnancy 6. Chronic autoimmune disease

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• endometriosis surgery
Laparoscopy was performed in the follicular phase of the woman's menstrual cycle and all recognizable endometriotic lesions were treated by bipolar coagulation, resection of endometriotic nodules and ovarian cystectomy.
• other benign condition surgeries
ovarian cystectomy, bilateral tubal ligation, myomectomy etc.

Locations
Country Name City State
Turkey Bagcilar Teaching and Research Hospital Istanbul Bagcilar

Sponsors (1)
Lead Sponsor Collaborator
Bagcilar Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Vodolazkaia A, El-Aalamat Y, Popovic D, Mihalyi A, Bossuyt X, Kyama CM, Fassbender A, Bokor A, Schols D, Huskens D, Meuleman C, Peeraer K, Tomassetti C, Gevaert O, Waelkens E, Kasran A, De Moor B, D'Hooghe TM. Evaluation of a panel of 28 biomarkers for th — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Diagnostic value of serum Annexin V in endometriosis To determine whether serum Annexin V levels (ng/mL) can be used as diagnostic markers of endometriosis disease. Up to 4 months
Primary Diagnostic value of serum sVCAM-1 in endometriosis To determine whether serum sVCAM-1(ng/mL) levels can be used as diagnostic markers of endometriosis disease. Up to 4 months
Primary Diagnostic value of serum sICAM-1 in endometriosis To determine whether serum sICAM-1(ng/mL) levels can be used as diagnostic markers of endometriosis disease. Up to 4 months
Primary Diagnostic value of serum Vascular Endothelial Growth Factor in endometriosis To determine whether serum Vascular Endothelial Growth Factor (pg/mL) levels can be used as diagnostic markers of endometriosis disease. Up to 4 months
Primary Diagnostic value of serum TNF-alpha in endometriosis To determine whether serum TNF-alpha (pg/mL) levels can be used as diagnostic markers of endometriosis disease. Up to 4 months
Primary Diagnostic value of serum Interleukin-6 in endometriosis To determine whether serum Interleukin-6 (pg/mL) levels can be used as diagnostic markers of endometriosis disease. Up to 4 months
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4

External Links